Invesco’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-23,460
Closed -$130K 3699
2020
Q2
$130K Buy
23,460
+4,900
+26% +$27.4K ﹤0.01% 3558
2020
Q1
$112K Buy
18,560
+1,850
+11% +$15.6K ﹤0.01% 3549
2019
Q4
$153K Sell
16,710
-640
-4% -$5.91K ﹤0.01% 3570
2019
Q3
$158K Sell
17,350
-600
-3% -$5.1K ﹤0.01% 3585
2019
Q2
$181K Sell
17,950
-4,700
-21% -$53.3K ﹤0.01% 3631
2019
Q1
$318K Sell
22,650
-2,318
-9% -$39.8K ﹤0.01% 3469
2018
Q4
$396K Buy
24,968
+51
+0.2% +$879 ﹤0.01% 3367
2018
Q3
$469K Sell
24,917
-908
-4% -$18.1K ﹤0.01% 3454
2018
Q2
$497K Buy
25,825
+145
+0.6% +$2.94K ﹤0.01% 3422
2018
Q1
$548K Sell
25,680
-600
-2% -$12.5K ﹤0.01% 3291
2017
Q4
$540K Sell
26,280
-4,070
-13% -$75.5K ﹤0.01% 3277
2017
Q3
$559K Buy
30,350
+7,720
+34% +$170K ﹤0.01% 3273
2017
Q2
$565K Buy
22,630
+7,680
+51% +$161K ﹤0.01% 3286
2017
Q1
$300K Sell
14,950
-3,440
-19% -$75.5K ﹤0.01% 3506
2016
Q4
$454K Buy
+18,390
New +$412K ﹤0.01% 3338

Other funds holding PMD

Invesco's PMD Position: Q3 2020 in Review

Invesco sold out of Psychemedics Corporation (PMD) in Q3 2020, closing a stake of 23,460 shares — an estimated $130K sold.

Invesco first reported a position in PMD in Q4 2016 and held it in 15 quarters. The position peaked at $565K in Q2 2017. 34 funds tracked by Wall St. Rank hold PMD as of Q3 2020.

  • Invesco reported no remaining Psychemedics Corporation position as of Q3 2020 after selling out during the quarter.
  • Invesco sold 23,460 Psychemedics Corporation shares in Q3 2020, an estimated $130K.
  • Invesco first reported a position in Psychemedics Corporation in Q4 2016 and held it in 15 quarters.
  • Invesco's Psychemedics Corporation position peaked at $565K in Q2 2017.
  • 34 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q3 2020.

Based on Invesco's 13F filing for Q3 2020, filed 16 Nov 2020.